Tag: ResMed

YARMOUTH, Maine – Manufacturers like ResMed and 3B Medical are ramping up production to meet increased demand due to a voluntary recall of millions of Philips CPAP devices, but their efforts are complicated by supply chain and other challenges.  “Yes, we’re ramping up production as quickly as possible, while working closely with our global supplier network to navigate the well-known global supply chain challenges impacting this and other industries,” said Jayme...

SAN DIEGO – People with untreated obstructive sleep apnea were associated with a higher rate of COVID-19 infection than those who received PAP treatment, according to a poster presented by ResMed and Kaiser Permanente during SLEEP 2021, which was held virtually June 10-13.  The data showed a dose-response association of OSA severity on infection rate: Patients with untreated mild OSA had a COVID-19 infection rate of 2%, while patients with severe untreated OSA had a COVID-19 infection...

SAN DIEGO, Calif. – ResMed has shipped more than 8,000 ventilators to hospitals in India since April and plans to ship more in the coming weeks, it says.    “ResMed stands strong with all the people in India as we provide support to mitigate the effects of its latest wave of COVID-19 cases and hospitalizations,” said Justin Leong, Asian and Latin American president. “We continue to work closely with our partners on the ground to gauge demand, and our global...

SAN DIEGO – The odds were against ResMed in a number of ways in the third quarter of fiscal year 2021, but the company expects a rebound in the next several quarters.  ResMed’s third quarter is typically slower due to insurance deductibles resetting in March, then the company faced a tough comparable – it generated $35 million in COVID-related revenues in the same quarter last year that haven’t been sustained.  “As we look further forward, we...

SAN DIEGO – A joint venture between ResMed and Verily to study the health and financial impacts of undiagnosed and untreated sleep apnea has been renamed Primasun.  ResMed and Verily, a subsidiary of Alphabet, first joined forces in 2018.  “We need a full night’s sleep right alongside a healthy diet and regular exercise for a strong immune system, the most energy, our best mood – in essence, to be our best selves,” said Primasun CEO Jonathon...

SAN DIEGO – ResMed is positioning a new online shop as a way for the manufacturer to be a “strong partner” for its HME provider customers.  The company last week launched shop.ResMed.com to sell its AirMini travel CPAP devices to cash-paying customers.  “By setting a benchmark for the online patient experience, we’re maximizing patients’ awareness of and demand for the products and services HMEs provide,”...

SAN DIEGO – ResMed on March 16 began offering its AirMini CPAP and related masks and accessories to cash-paying customers through a new website shop.ResMed.com.  “Over 54 million Americans have sleep apnea – over 80% of whom are undiagnosed,” the company states. “Our mission is to drive awareness of the disease, plus how easy and effective today’s digitally connected home solutions are. We believe this will further normalize the condition,...

SAN DIEGO – For half of Americans, stress over the past year of the pandemic is negatively impacting the quality of their sleep, according to the results of nationwide survey of 1,000 adults conducted by ResMed.  While COVID-related stresses are often noticeable, one of the biggest stealers of sleep might be something people can’t easily detect: sleep apnea, the company says.  “While data show that stress and worry are key factors impacting many people’s...

SAN DIEGO – ResMed incurred a $13.9 million restructuring expense in the second quarter of its fiscal year 2021 as a result of closing its portable oxygen concentrator business.  The company stopped selling its Mobi POCs in November.  “Going forward, the cessation of the POC business will have an immaterial impact on both group revenue and earnings per share,” said Brett Sandercock, CFO, during a conference call on...

SAN DIEGO – ResMed reported revenues increased to $800 million for the three months ended Dec. 31, 2020, a 7% increase compared to the same period in 2019.  Net income was $179.5 million vs. $160.6 million.  “Our second quarter results reflect continued solid performance and positive trends across our business, resulting in top-line growth,” said Mick Farrell, CEO. “In our core markets of sleep apnea, COPD and asthma, we are seeing continued sequential improvement...